What is the recommended dose of aspirin (acetylsalicylic acid) for secondary prevention after a stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aspirin Dosage for Secondary Stroke Prevention

For secondary prevention after a stroke, low-dose aspirin (75-100 mg daily) is recommended as it provides effective protection against recurrent stroke while minimizing bleeding risks. 1

Evidence-Based Dosing Recommendations

The optimal aspirin dose for secondary stroke prevention has been established through multiple guidelines and clinical trials:

  • The American Heart Association/American Stroke Association recommends aspirin 75-100 mg daily for secondary stroke prevention 1
  • The European Society of Cardiology supports low-dose aspirin (75-100 mg daily) for long-term secondary prevention 1
  • Canadian Stroke Best Practice Recommendations suggest maintenance doses of 81-325 mg daily after an initial loading dose 1

Acute vs. Maintenance Dosing

There is an important distinction between initial and maintenance dosing:

  • Initial loading dose: 160-325 mg immediately after stroke diagnosis and exclusion of hemorrhage 1, 2
  • Maintenance dose: 75-100 mg daily for long-term secondary prevention 1

Rationale for Low-Dose Recommendation

The recommendation for low-dose aspirin is based on:

  1. Equivalent efficacy: Studies show that low doses (75-100 mg) are as effective as higher doses for long-term stroke prevention 1, 3

  2. Reduced adverse effects: Higher doses increase the risk of gastrointestinal bleeding without providing additional preventive benefit 1, 3

  3. Long-term safety: Daily aspirin doses of 75-100 mg provide the optimal balance between antithrombotic efficacy and bleeding risk 1

Special Considerations

Dual Antiplatelet Therapy

  • Short-term dual antiplatelet therapy (aspirin plus clopidogrel) may be beneficial for 21-30 days after minor stroke or high-risk TIA 1
  • After this period, patients should return to antiplatelet monotherapy with aspirin 75-100 mg daily 1

Alternative Antiplatelet Options

  • For patients intolerant to aspirin, clopidogrel 75 mg daily is a reasonable alternative 1
  • The PRoFESS trial found no significant difference between clopidogrel and aspirin-dipyridamole for secondary stroke prevention 1

Common Pitfalls to Avoid

  1. Using excessive doses: Higher maintenance doses (>100 mg daily) increase bleeding risk without improving efficacy 1, 3

  2. Inadequate initial loading: Failing to provide an adequate loading dose (160-325 mg) in the acute setting 1, 2

  3. Prolonged dual antiplatelet therapy: Continuing aspirin plus clopidogrel beyond 30 days increases bleeding risk without additional benefit for most patients 1

  4. Delayed initiation: Aspirin should be started within 24-48 hours after stroke onset (after excluding hemorrhage) 2

  5. Premature discontinuation: Long-term adherence is essential as secondary prevention benefits continue indefinitely 1

In conclusion, while higher doses (160-325 mg) are appropriate for the initial treatment of acute ischemic stroke, the evidence strongly supports transitioning to low-dose aspirin (75-100 mg daily) for long-term secondary prevention to optimize the balance between efficacy and safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Ischemic Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.